Comparison of Plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) Level in De-resuscitation With Furosemide Group and Control Group

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions
Acute Kidney Injury Due to Sepsis
Interventions
PROCEDURE

Furosemide Injection

Continuous infusion of furosemide is administered starting at 2 mg/hour and can be titrated until the target urine output of 1-2 cc/kg/hour is achieved for 48 hours. In case of hypotension (MAP \<65 mmHg), norepinephrine is administered with titration starting at a dose of 0.05 mcg/kg/minute, along with a fluid loading of 4 cc/kg body weight or 300 cc within 5-10 minutes, until the target MAP of ≥65 mmHg is reached for 48 hours.

PROCEDURE

Placebo Injection

Continuous infusion of placebo fluid is administered at a rate of 2 mL/hour. In case of hypotension (MAP \<65 mmHg), norepinephrine is administered with titration starting at a dose of 0.05 mcg/kg/minute, along with a fluid loading of 4 cc/kg body weight or 300 cc within 5-10 minutes, until the target MAP of ≥65 mmHg is reached for 48 hours.

Trial Locations (1)

10430

Rumah Sakit Cipto Mangunkusumo, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER